Lantern Pharma (LTRN) Tops Q1 EPS by 12c
Lantern Pharma (NASDAQ: LTRN) reported Q1 EPS of ($0.36), $0.12 better than the analyst estimate of ($0.48).
For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.
Lantern Pharma (NASDAQ: LTRN) reported Q1 EPS of ($0.36), $0.12 better than the analyst estimate of ($0.48).
For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.